Busan is good

Busan’s Biohealth Technology Proven at Singapore Medical Device Exhibition

내용

Busan Metropolitan City, led by Mayor Chun Jae-soo, announced that it operated a Busan Pavilion at Medical Fair Asia 2026, Southeast Asia’s largest medical device exhibition, held in Singapore from September 9 to 11, to support local medical device and healthcare companies in expanding into overseas markets.

The exhibition, held at The Sands Expo and Convention Centre in Singapore, brought together approximately 1,000 companies from more than 40 countries, including 73 Korean companies, and attracted approximately 14,000 visitors. Four exhibitions, including the medical device exhibition, were held concurrently.

Busan Metropolitan City formed and operated the Busan Pavilion for three days with a total of 10 companies, including six participating in the Senior-Friendly Industry Development Support Project and four participating in the Global High-Med Hub Special Zone Win-Win Cooperation Project.

Both projects are managed and operated on a commissioned basis by Busan Techno Park.

During the exhibition, companies in the Busan Pavilion held a total of 190 consultations worth USD 4,927,200, approximately KRW 6.8 billion. Of this amount, prospective contracts totaled USD 1.011 million, approximately KRW 1.4 billion, while contracts signed on site totaled USD 81,000, approximately KRW 110 million.

By participating company, Sunworld Korea Co., Ltd. recorded the highest consultation value at USD 1,072,700, approximately KRW 1.48 billion, followed by Doctor Q Plus Co., Ltd. at USD 1.027 million, approximately KRW 1.42 billion. Hakam Bio Co., Ltd. recorded the highest number of consultations, with 28 cases.

Considering that the medical and healthcare consumables and devices exhibited were priced from tens of thousands of won to as much as KRW 2 million per item, the total consultation value of USD 4,927,200, approximately KRW 6.8 billion, is regarded as a meaningful result with the potential to lead to large-scale exports.

In particular, on the final day of the exhibition, a Singapore-based distribution company signed separate memoranda of understanding with Ami Global Co., Ltd. and Seongchangsa Co., Ltd., generating a combined result worth USD 30,000, approximately KRW 41 million.

The distribution company supplies products to approximately 50 local physical therapy specialty shops and five general hospitals and expressed strong satisfaction with the product quality and price competitiveness of the Busan companies.

During the exhibition, Busan Metropolitan City also participated in a networking event for the Korea-Singapore Biohealth Partnership organized by KOTRA, promoting Busan’s medical device and healthcare companies as well as related industries.

At the networking event, attended by companies participating in the Korea Pavilion and Singaporean buyers, Busan Metropolitan City introduced the companies participating in the Busan Pavilion, its policies for fostering the medical device industry, and Busan Healthcare Week, and provided information on the invitation process for Healthcare Week.

Local buyers who attended the networking event visited the Busan Pavilion the following day, examined the participating companies’ products firsthand, and expressed interest in visiting Busan Healthcare Week.

As Singapore had not previously been among the countries represented by overseas buyers visiting Busan Healthcare Week, Busan Metropolitan City used the exhibition as an opportunity to establish new connections with Singaporean buyers.

Busan Metropolitan City also visited the headquarters of Prestige Biopharma, a biohealth anchor company that operates the Innovative Discovery Center, an R&D hub in Busan, to discuss cooperation measures.

The two sides agreed to continue working together to help the Busan Innovative Discovery Center grow into an anchor company for the regional biohealth cluster and also discussed administrative support measures that Busan Metropolitan City could provide.

Kim Dong-hyun, Director General of the AI Industry Innovation Bureau, said, “This exhibition provided an opportunity to directly confirm the technological capabilities and product competitiveness of Busan companies in the global market. As it produced tangible results, including establishing new connections with Singaporean buyers with strong purchasing power and strengthening cooperation with an anchor company, we will make every effort to provide administrative support so that follow-up cooperation can proceed smoothly.”